APASL Oncology 2022 (APASL STC in Takamatsu).
Industry / Supported Symposium
Day 1: September 1 (Thursday) 2022
Luncheon Seminar 1 Sponsored by Chugai Pharmaceutical Co., Ltd.
12:30-13:30 (JST)Room 1
- Chair: Dr. Kiyoshi Hasegawa (Japan)
- Future Prospects for Hepatocellular Carcinoma Treatment Through Immune Control
- Dr. Nobuhiro Nakamoto (Japan)
- Recent Advances in Systemic Therapy for Unresectable Hepatocellular Carcinoma ~Atezolizumab Plus Bevacizumab Therapy in Real-world Practice~
- Dr. Kaoru Tsuchiya (Japan)
Luncheon Seminar 2 Sponsored by Gilead Sciences K.K.
12:30-13:30 (JST)Room 2
- Chair: Dr. Norifumi Kawada (Japan)
- Role of Medical AI for the Management of Liver Disease in the Era of Viral Elimination
- Dr. Naoshi Nishida (Japan)
Day 2: September 2 (Friday) 2022
Morning Seminar 1Sponsored by Otsuka Pharmaceutical Co., Ltd.
8:00-9:00 (JST)Room 1
- Chair: Dr. Koichi Takaguchi (Japan)
- Total Therapeutic Management of Liver Disease
- Dr. Atsushi Hiraoka (Japan)
- Real-world Evidences of Systemic Therapy for Hepatocellular Carcinoma
- Dr. Masayuki Kurosaki (Japan)
Luncheon Seminar 3 Sponsored by AbbVie GK
12:30-13:30 (JST)Room 1
- Chair: Dr. Hitoshi Yoshiji (Japan)
- Real-word Direct-acting Antivirals Treatment for Chronic Hepatitis C Patients with Chronic Kidney Disease in Japan
- Dr. Masanori Atsukawa (Japan)
Morning Seminar 2Sponsored by Asahi Kasei Pharma Corporation
8:00-9:00 (JST)Room 2
- Chair: Dr. Keiichi Okano (Japan)
- Treatment Strategies for Acute Cholangitis
- Dr. Hideki Kamada (Japan)
Luncheon Seminar 4 Sponsored by Eisai Co., Ltd. / MSD K.K.
12:30-13:30 (JST)Room 2
- Chair: Dr. Junji Furuse (Japan)
- Value of LEN + IVR Therapy in the Treatment of HCC Based on Clinical Practice
- Dr. Hideki Iwamoto (Japan)
- The Dawn of New Surgical Strategy for Advanced Hepatocellular Carcinoma
- Dr. Junichi Shindoh (Japan)
Day 3: September 3 (Saturday) 2022
Morning Seminar 3 Sponsored by AI Medical Service Inc.
8:00-9:00 (JST)Room 1
- Chair: Dr. Kiyoshi Hasegawa (Japan)
- “The Impact of AI on Tomorrow’s Endoscopic Medicine”
- Current Status and Future of AI in Digestive Disease
- Dr. Yuzo Kodama (Japan)
- Taking on the World with Japanese Endoscopic AI
- Dr. Tomohiro Tada (Japan)
- Special Comment Dr. Tetsuji Takayama (Japan)
Morning Seminar 4 Sponsored by Takeda Pharmaceutical Co., Ltd.
8:00-9:00 (JST)Room 2
- Chair: Dr. Makoto Oryu (Japan)
- Positioning of Vonoprazan and Its Safety - Seven Years of Clinical Experience in Japan
- Dr. Ken Haruma (Japan)
CopyrightAPASL Oncology 2022 (APASL STC in Takamatsu).